Table 1 Baseline characteristics of women without cancer and women with local or systemic cancer
From: Responses to fertility treatment among patients with cancer: a retrospective cohort study
| Characteristics at cycle start | No Cancer (n = 664) | Local Cancer (n = 105) | Systemic Cancer (n = 42) |
|---|---|---|---|
| Woman’s Age at Stimulation, years (mean ± SD) | 34.6 ± 4.2 | 33.6 ± 4.8 | 27.1 ± 6.4 |
| Baseline Antral Follicle Count (mean ± SD) (missing, n = 48) | 9.4 ± 7.2 | 10.1 ± 7.4 | 7.3 ± 7.5 |
| AMH, ng/mL (mean ± SD) | 3.4 ± 3.3 | 2.8 ± 2.7 | 2.0 ± 2.2 |
| Cycle Day 2–4 FSH, mIU/mL (mean ± SD) (missing, n = 91) | 7.2 ± 2.3 | 9.6 ± 19.8 | 9.1 ± 6.3 |
| Woman’s BMI at Stimulation, kg/m2 (mean ± SD) | 25.7 ± 4.2 | 26.0 ± 6.3 | 24.9 ± 5.9 |
| Woman’s Race (n [%]) | |||
| Caucasian | 466 (70.2%) | 88 (86.2%) | 36 (85.7%) |
| Other | 198 (29.8%) | 14 (13.7%) | 6 (14.3%) |
| Current Smoker (n [%]) | 17 (2.6%) | 6 (5.7%) | 0 (0%) |
| Gravida (n [%]) | 186 (28.3%) | 35(33.3%) | 7 (16.7%) |
| Cycle Type (n [%]) | |||
| GnRH antagonist | 88 (13.3%) | 103 (98.1%) | 36 (85.7%) |
| Down-regulation | 533 (80.3%) | 1 (1.0%) | 4 (9.5%) |
| Gonadotropin only | 3 (0.5%) | 1 (1.0%) | 2 (4.8%) |
| Poor-responder protocols | 40 (6.0%) | 0 (0%) | 0 (0%) |
| Start of Stimulation (n [%]) | |||
| Conventional/Early Follicular | 664 (100.0%) | 84 (80.0%) | 25 (59.5%) |
| Random Start | 0 (0%) | 16 (14.3%) | 17 (40.5%) |
| Late Follicular | 0 (0%) | 3 (2.9%) | 2 (4.8%) |
| Luteal | 0 (0%) | 7 (6.7%) | 5 (11.9%) |
| Total Motile Post-wash Sperm Count, 106 (mean ± SD) | 5.66 ± 16.88 | 28.9 ± 33.4 | 34.8 ± 41.5 |
| ICSI (n [%]) | 547 (85.6%) | 21 (21.7%) | 4 (11.4%) |